Department of Dentistry-Regenerative Biomaterials, Radboud University Medical Center, Nijmegen 6525 EX, The Netherlands.
Department of Medical BioSciences, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.
ACS Biomater Sci Eng. 2024 Nov 11;10(11):6964-6973. doi: 10.1021/acsbiomaterials.4c01283. Epub 2024 Oct 7.
Hydroxyapatite nanoparticles (nHA) have gained attention as potential intracellular drug delivery vehicles due to their high binding affinity for various biomolecules and pH-dependent solubility. Yet, the dependence of nHA cytocompatibility on their physicochemical properties remains unclear since numerous studies have revealed starkly contrasting results. These discrepancies may be attributed to differences in size, shape, crystallinity, and aggregation state of nHA, which complicates fundamental understanding of the factors driving nHA cytotoxicity. Here, we hypothesize that nHA cytotoxicity is primarily driven by intracellular calcium levels following the internalization of nHA nanoparticles. By investigating the cytotoxicity of spherical nHA with different crystallinity and dispersity, we find that both lower crystallinity and increased agglomeration of nHA raise cytotoxicity, with nanoparticle agglomeration being the more dominant factor. We show that the internalization of nHA enhances intracellular calcium levels and increases the production of reactive oxygen species (ROS). However, only subtle changes in intracellular calcium are observed, and their physiological relevance remains to be confirmed. In conclusion, we show that nHA agglomeration enhances ROS production and the associated cytotoxicity. These findings provide important guidelines for the future design of nHA-containing formulations for biomedical applications, implying that nHA crystallinity and especially agglomeration should be carefully controlled to optimize biocompatibility and therapeutic efficacy.
羟基磷灰石纳米颗粒(nHA)由于其对各种生物分子的高结合亲和力和 pH 依赖性溶解度,已引起人们对其作为潜在细胞内药物递送载体的关注。然而,nHA 细胞相容性对其物理化学性质的依赖性尚不清楚,因为许多研究表明了截然不同的结果。这些差异可能归因于 nHA 的尺寸、形状、结晶度和聚集状态的差异,这使得对驱动 nHA 细胞毒性的因素的基本理解变得复杂。在这里,我们假设 nHA 细胞毒性主要是由内吞 nHA 纳米颗粒后细胞内钙离子水平的变化引起的。通过研究具有不同结晶度和分散性的球形 nHA 的细胞毒性,我们发现 nHA 的结晶度降低和聚集增加都会提高细胞毒性,而纳米颗粒聚集是更主要的因素。我们表明,nHA 的内化会增加细胞内钙离子水平并增加活性氧(ROS)的产生。然而,仅观察到细胞内钙离子的细微变化,其生理相关性仍有待证实。总之,我们表明 nHA 聚集增强了 ROS 的产生及其相关的细胞毒性。这些发现为未来设计用于生物医学应用的含 nHA 制剂提供了重要指导,表明 nHA 的结晶度,尤其是聚集度应得到仔细控制,以优化生物相容性和治疗效果。